The outbreak of novel coronavirus 2019-nCoV ("Coronavirus") is an extraordinary challenge for many transactions involving Chinese companies. In this section, we analyse its impact on certain key aspects of mergers and...more
2/18/2020
/ Best Practices ,
China ,
Coronavirus/COVID-19 ,
Corporate Sales Transactions ,
Covered Transactions ,
Financial Markets ,
Force Majeure Clause ,
Infectious Diseases ,
Investment ,
Investor Protection ,
Investors ,
Joint Venture ,
Market Conditions ,
Material Adverse Effects ,
Public Health ,
Risk Management ,
Share Purchase Agreements
Much has already been written about the foreign investment law which was voted into law by China's highest legislative body, the National People's Congress of the People's Republic of China, on 15 March 2019.
...more
On 30 June 2016, the industry self-regulating body, the Asset Management Association of China published what, on the face of it, appeared to be a fairly innocuous document entitled Questions and Answers regarding the...more
On 30 June 2016, the industry self-regulating body, the Asset Management Association of China published what, on the face of it, appeared to be a fairly innocuous document entitled Questions and Answers regarding the...more
3/23/2017
/ CEPA ,
China ,
China Securities Regulatory Commission (CSRC) ,
Financial Institutions ,
Financial Markets ,
Foreign Investment ,
Foreign-Owned Corporations ,
Investment Funds ,
Investment Management ,
Joint Venture ,
MOFCOM ,
Private Funds ,
Regulatory Oversight